SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001144204-17-015881
Filing Date
2017-03-21
Accepted
2017-03-21 17:09:19
Documents
5
Effectiveness Date
2017-03-21

Document Format Files

Seq Description Document Type Size
1 S-8 v461778_s8.htm S-8 72585
2 EXHIBIT 5.1 v461778_ex5-1.htm EX-5.1 13517
3 EXHIBIT 23.1 v461778_ex23-1.htm EX-23.1 3490
4 EXHIBIT 23.2 v461778_ex23-2.htm EX-23.2 3266
5 GRAPHIC image_001.jpg GRAPHIC 20373
  Complete submission text file 0001144204-17-015881.txt   122052
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 212-554-4366
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-216856 | Film No.: 17704853
SIC: 2834 Pharmaceutical Preparations